Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHAR Gel for Chronic Pulmonary Sarcoidosis
NCT02188017Phase 4Unknown
- Sponsor
- University of Cincinnati
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in pulmonary sarcoidosis, sponsored by University of Cincinnati. Status: unknown.
02
Drugs
repository corticotropin injection
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT02188017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188017.